Titre :
  • Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2
Auteur : Gnant, Michael ; Baselga, José ; Rugo, Hope ; Noguchi, Shinzaburo S. ; Burris, Howard H.A. ; Piccart-Gebhart, Martine ; Hortobagyi, Gabriel N. ; Eakle, Janice J. ; Hart, Lowell L.L. ; Mukai, Hirofumi H. ; Iwata, Hiroji ; Geberth, Matthias M. ; Hadji, Peyman ; El-Hashimy, Mona M. ; Rao, Shantha S. ; Taran, Tetiana T. ; Sahmoud, Tarek ; Lebwohl, David ; Campone, Mario ; Pritchard, Kathleen
Informations sur la publication : Journal of the National Cancer Institute, 105, 9, (page 654-663)
Statut de publication : Publié, 2013-05
Sujet CREF : Cancérologie
Mots-clés MeSH : Aged
Alkaline Phosphatase -- blood
Androstadienes -- administration & dosage
Antineoplastic Agents -- pharmacology -- therapeutic use
Aromatase Inhibitors -- administration & dosage
Bone Density -- drug effects
Bone Density Conservation Agents -- pharmacology -- therapeutic use
Bone Neoplasms -- blood -- metabolism -- prevention & control -- secondary
Bone Remodeling -- drug effects
Bone Resorption -- drug therapy -- prevention & control
Breast Neoplasms -- blood -- chemistry -- pathology
Collagen Type I -- metabolism
Confounding Factors (Epidemiology)
Disease Progression
Disease-Free Survival
Drug Administration Schedule
Female
Follow-Up Studies
Fractures, Spontaneous -- etiology -- prevention & control
Humans
Middle Aged
Odds Ratio
Osteogenesis -- drug effects
Postmenopause
Procollagen -- blood
Proportional Hazards Models
Receptors, Estrogen -- analysis
Sirolimus -- analogs & derivatives -- pharmacology -- therapeutic use
TOR Serine-Threonine Kinases -- antagonists & inhibitors
Treatment Failure
Treatment Outcome
Note : SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0027-8874 
info:doi/10.1093/jnci/djt026
info:pii/djt026
info:pmid/23425564